Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ocugen Inc (OCGN)

Ocugen Inc (OCGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 288,237
  • Shares Outstanding, K 257,354
  • Annual Sales, $ 6,040 K
  • Annual Income, $ -63,080 K
  • 60-Month Beta 3.69
  • Price/Sales 55.80
  • Price/Cash Flow N/A
  • Price/Book 18.40
Trade OCGN with:

Options Overview Details

View History
  • Implied Volatility 115.94% ( -8.31%)
  • Historical Volatility 71.84%
  • IV Percentile 13%
  • IV Rank 4.24%
  • IV High 1,030.35% on 11/09/23
  • IV Low 75.50% on 02/07/24
  • Put/Call Vol Ratio 0.34
  • Today's Volume 350
  • Volume Avg (30-Day) 729
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 60,222
  • Open Int (30-Day) 57,807

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.05
  • Number of Estimates 2
  • High Estimate -0.04
  • Low Estimate -0.05
  • Prior Year -0.06
  • Growth Rate Est. (year over year) +16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1000 +1.82%
on 09/18/24
1.4000 -20.00%
on 08/26/24
-0.1200 (-9.68%)
since 08/16/24
3-Month
1.0800 +3.70%
on 08/05/24
1.9790 -43.41%
on 07/16/24
-0.2600 (-18.84%)
since 06/18/24
52-Week
0.3450 +224.64%
on 10/26/23
2.1050 -46.79%
on 03/25/24
+0.7200 (+180.00%)
since 09/18/23

Most Recent Stories

More News
2 Penny Stocks That Wall Street Believes Can Soar Around 292% to 442%

Analysts believe these two penny stocks have outstanding long-term potential.

ATOS : 1.4200 (-2.07%)
OCGN : 1.1200 (unch)
$SPX : 5,618.26 (-0.29%)
Ocugen (OCGN) Q2 2024 Earnings Call Transcript

OCGN earnings call for the period ending June 30, 2024.

OCGN : 1.1200 (unch)
Ocugen: Q2 Earnings Snapshot

Ocugen: Q2 Earnings Snapshot

OCGN : 1.1200 (unch)
1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid

These two stocks could have vastly different long-term performances.

CRSP : 49.59 (-0.56%)
OCGN : 1.1200 (unch)
1 Stock That More Than Doubled This Year That I Wouldn't Touch With a 10-Foot Pole

Don't jump on the bandwaggon.

OCGN : 1.1200 (unch)
Can Ocugen Stock Keep Churning Higher?

This tiny biotech caught fire in 2024. Can it sustain the momentum?

RHHBY : 39.6100 (+0.71%)
VHT : 284.83 (-0.19%)
OCGN : 1.1200 (unch)
3 Standout Penny Stocks to Watch This April

Investing in penny stocks carries substantial risk, but also offers the potential for significant returns. These penny stocks, all with bullish analyst ratings, have considerable upside potential, according...

OCGN : 1.1200 (unch)
VERU : 0.7700 (-1.67%)
DM : 4.68 (-0.21%)
$SPX : 5,618.26 (-0.29%)
Ocugen (OCGN) Q4 2023 Earnings Call Transcript

OCGN earnings call for the period ending March 31, 2024.

OCGN : 1.1200 (unch)
Two Beaten-Down Stocks That Could Soar 170% and 630%, Respectively, According to Wall Street

Could these biotech companies still win in the vaccine market and beyond?

NVAX : 12.56 (-2.86%)
OCGN : 1.1200 (unch)
Ocugen (OCGN) Q3 2023 Earnings Call Transcript

OCGN earnings call for the period ending September 30, 2023.

OCGN : 1.1200 (unch)

Business Summary

Ocugen Inc. is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing therapies which address rare and underserved eye diseases. The company's product pipeline consists of OCU400, OCU300, OCU100 and OCU200 which are in clinical stage. Ocugen Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 1.2467
2nd Resistance Point 1.2133
1st Resistance Point 1.1667
Last Price 1.1200
1st Support Level 1.0867
2nd Support Level 1.0533
3rd Support Level 1.0067

See More

52-Week High 2.1050
Fibonacci 61.8% 1.4327
Fibonacci 50% 1.2250
Last Price 1.1200
Fibonacci 38.2% 1.0173
52-Week Low 0.3450

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar